185 related articles for article (PubMed ID: 12193924)
1. Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.
Ohkouchi T; Sakuragi N; Watari H; Nomura E; Todo Y; Yamada H; Fujimoto S
Am J Obstet Gynecol; 2002 Aug; 187(2):353-9. PubMed ID: 12193924
[TBL] [Abstract][Full Text] [Related]
2. p53 overexpression as a prognostic indicator in endometrial carcinoma.
Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G
Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239
[TBL] [Abstract][Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression and prognosis of patients with endometrial carcinoma.
Sakuragi N; Ohkouchi T; Hareyama H; Ikeda K; Watari H; Fujimoto T; Kuwabara M; Yamamoto R; Sagawa T; Fujino T; Fujimoto S
Int J Cancer; 1998 Apr; 79(2):153-8. PubMed ID: 9583730
[TBL] [Abstract][Full Text] [Related]
8. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation and lymph node metastasis in surgically staged endometrial carcinoma.
Pilka R; Marková I; Dusková M; Procházka M; Tozzi M; Kudela M
Eur J Gynaecol Oncol; 2010; 31(5):530-5. PubMed ID: 21061794
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma.
Soong R; Knowles S; Williams KE; Hammond IG; Wysocki SJ; Iacopetta BJ
Br J Cancer; 1996 Aug; 74(4):562-7. PubMed ID: 8761370
[TBL] [Abstract][Full Text] [Related]
11. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
Bell JG; Minnick A; Reid GC; Judis J; Brownell M
Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
13. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
16. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of p53 overexpression in endometrial cancers.
Inoue M; Okayama A; Fujita M; Enomoto T; Sakata M; Tanizawa O; Ueshima H
Int J Cancer; 1994 Jul; 58(1):14-9. PubMed ID: 8014010
[TBL] [Abstract][Full Text] [Related]
18. [Expression of p53 protein in women with endometrial cancer].
Ivanov S; Khadzhiolov N; Ivanov S
Akush Ginekol (Sofiia); 2001; 40(4):14-5. PubMed ID: 11803862
[TBL] [Abstract][Full Text] [Related]
19. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
20. P53 and BCL-2 as prognostic markers in endometrial carcinoma.
Appel ML; Edelweiss MI; Fleck J; Rivero LF; Rivoire WA; Mônego HI; Dos Reis R
Pathol Oncol Res; 2008 Mar; 14(1):23-30. PubMed ID: 18398703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]